Comparative Radioimmunotherapy in Colonic Tumor Model
Author Information
Author(s): R.B. Pedley, J.A. Boden, R. Boden, R. Dale, R.H.J. Begent
Primary Institution: Royal Free Hospital School of Medicine
Hypothesis
The study compares the therapeutic efficacy of intact and F(ab')2 fragments of a radiolabelled anti-CEA antibody in a colonic xenograft model.
Conclusion
Both intact and F(ab')2 fragments significantly delayed tumor growth and increased survival time, but the fragments cleared more rapidly from circulation.
Supporting Evidence
- A single IV dose of either 0.5 mCi intact or 1.0 mCi F(ab')2 fragments significantly delayed tumor growth.
- The fragments showed improved tumor:normal tissue ratios due to rapid clearance from circulation.
- Fractionating the F(ab')2 dose reduced the therapeutic effect compared to a single dose.
Takeaway
The study tested two types of cancer treatment using antibodies and found that both worked well, but one type left the body faster.
Methodology
The study involved administering either intact or F(ab')2 fragments of a radiolabelled anti-CEA antibody to nude mice with colonic xenografts and measuring tumor growth and survival.
Limitations
The study was conducted in a mouse model, which may not fully represent human responses.
Participant Demographics
Female nude mice, aged 2-3 months, weighing 20-25 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website